Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
A 2025 systematic review by Vasireddi and colleagues in HSS Journal screened 544 published papers and identified 36 meeting inclusion criteria 35 preclinical studies and only one human study: an uncontrolled, unblinded, retrospective case series of 12 patients receiving intra-articular BPC-157 for chronic knee pain, in which 7 of 12 (58%) reported self-described relief lasting more than 6 months, with no dose, effect size, or systematically collected adverse events published
Component B: TB-500 (Synthetic Thymosin Beta-4 Fragment) TB-500 is a synthetic version of the naturally occurring protein Thymosin Beta-4 (T4)
Each vial is supplied as a lyophilized powder with documented purity exceeding 99% by HPLC, verified through third-party testing, and accompanied by certificates of analysis when available
Some people report mild injection site warmth or a subtle sense of increased blood flow to the area
US$ 24.91
US$ 25.85
US$ 28.04
